Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Tomaszek Barbara

14 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 6 Receptor Pharmacology 6 Review Article 4 Treatment-Resistant Depression 4 Clinical Trial 4 Addiction 3 Mechanism of Action 3 Safety 2 Adverse Events 2 Neuroplasticity 2 Chronic Pain 2 Spirituality 2

Journals

Pharmacological reports: PR 2 International Journal of Innovative Technologies in Social Science 1 European Journal of Neuroscience 1 Psychotherapy and Psychosomatics 1 JAMA Psychiatry 1 Nature communications 1 Psychotherapy (Chicago, Ill.) 1 The international journal of neuropsychopharmacology 1

Publication history

PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEWInternational Journal of Innovative Technologies in Social Science · 2026-06-24 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-06-01 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27 Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01 Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.Nature communications · 2025-11-20 A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy (Chicago, Ill.) · 2025-09-01 426. THE MGLUR2/3 ANTAGONIST ENHANCES THE BEHAVIORAL AND CELLULAR ANTIDEPRESSANT-LIKE EFFECTS OF PSILOCYBIN AND SCOPOLAMINEThe international journal of neuropsychopharmacology · 2025-08-01 Psilocybin-assisted treatment of depressionMedical Science · 2025-07-30 Psilocybin in pharmacotherapy of obsessive-compulsive disorder.Pharmacological reports: PR · 2024-10-01 Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.Pharmacological reports: PR · 2023-12-01 High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybinbioRxiv · 2023-04-14 [Addictions].Revue medicale suisse · 2020-01-15 Can Psilocybin Treat Severe DepressionJournal watch · 2017-11-03 Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.Neurology · 1962-09-01

Author directory